NCT01763996View on ClinicalTrials.gov

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Coronary Artery Disease
Interventions
DRUG

Febuxostat

Febuxostat capsules

DRUG

Febuxostat placebo

Febuxostat placebo-matching capsules

Trial Locations (1)

Unknown

Baltimore

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01763996 - The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina | Biotech Hunter | Biotech Hunter